Exosome Therapy

Small packages released by cells that carry proteins, fats and RNA. Researchers are studying how these signals might be used in treatment, and which products, routes and conditions have evidence behind them.

Understanding Exosome Therapy

By Jed Ryan, Founder and CEO · Published · Updated

Gold line illustration of a human brain

Cells release small membrane-bound packages called extracellular vesicles, or EVs. Their cargo can influence other cells. Exosomes are one type of EV, and preparations described as exosomes are not necessarily identical in what they contain or how they are made.

Some EV preparations have crossed the blood-brain barrier in animal experiments. That does not show that every preparation reaches the human brain in useful amounts. Size alone cannot establish delivery, benefit or safety.

Gold line illustration of a human brain

The scientific interest comes from this ability to carry biological signals. The MISEV research guidance explains why source, separation, testing and storage all matter when comparing EV preparations.

Before considering an MSC-derived EV preparation, ask the clinical team for product-specific answers:

  • Identity: Which cells produced it, and what tests characterize its contents?
  • Delivery: What evidence supports the proposed route for your condition?
  • Quality: How are contamination, storage and biological activity checked?
  • Follow-up: How will benefit, side effects and unexpected problems be assessed?

A manufacturing standard is one part of that discussion. It does not establish that a particular product works for a condition. The treating team should explain the proposed preparation, its evidence and the applicable local requirements.

Go Deeper▾

What Researchers Are Testing

The potential is worth exploring. The result still has to be measured in the people and conditions being treated.

Delivery to the Brain

Animal studies show brain uptake can vary between EV preparations. Human delivery and treatment benefit need their own evidence.

Inflammatory Signals

Researchers measure effects on inflammatory signals. A laboratory change is not the same as improved symptoms.

Tissue Repair

Cell and animal findings help identify possible repair mechanisms. Clinical studies must test meaningful healing outcomes.

Immune Response

EV cargo can affect immune cells. The direction and clinical importance depend on the preparation and setting.

Product-Specific Safety

A cell-free preparation still needs safety and quality assessment. It cannot be assumed safer because it contains no living cells.

Combination Treatment

Adding EVs to a cell protocol does not automatically improve its outcome. Ask what evidence supports the combination.

Where EVs Are Being Studied

These are research topics, not a list of proven indications. Evidence needs to match the product, condition and route.

Illustration of a neuron
Illustration of a neuron

Neurological

Researchers are investigating EV delivery and effects in neurological disease models. Much of this work is preclinical. Animal brain uptake does not establish recovery in people or support every preparation offered for these conditions:

Alzheimer's / Dementia Parkinson's Disease Multiple Sclerosis TBI / Concussion Stroke Recovery ALS

Autoimmune & Inflammatory

Researchers study EV effects on immune signalling in cells, animals and selected clinical settings. These findings do not establish that a proposed preparation controls an autoimmune illness. Topics to discuss with the clinical team include:

Rheumatoid Arthritis Lupus Crohn's / IBD Chronic Inflammation

Tissue Repair & Longevity

Repair research includes laboratory experiments and small human studies. A result in one wound type or product cannot establish faster recovery elsewhere, and wound healing is not proof of longer life. Related topics include:

Chronic Wounds Athletic Recovery Skin Regeneration Longevity & Anti-Aging

The research behind
exosomes

Microscope illustration

A mouse study found that ten EV populations crossed the blood-brain barrier at different rates. In a small human trial, platelet-derived EVs did not shorten healing time in healthy volunteers' biopsy wounds. That product was not MSC-derived, and the trial does not settle other uses. Read each study with its preparation and limitations in view.

Explore the Research

Treatment Process

Strong Craft Regen helps you arrange a clinical consultation. The treating medical team assesses suitability and decides whether any treatment is appropriate.

01

Discovery Call

An exploratory conversation with Jed, for us to understand what you've been dealing with and how we can best help.

02

Medical Consultation

A consultation with the treating medical team to review your history, discuss the evidence and consider suitable options. Dr. Darinskas provides scientific input.

03

Individualized Protocol

The treating medical team decides what to recommend, explains alternatives and risks, and agrees on how your progress will be assessed.

04

Your Treatment

The clinical team confirms the treatment location and availability for your case. We help with scheduling and travel information; you arrange and pay for your flights and accommodation.

What Our Clients Are Saying

Read the experiences clients have chosen to share.

Client Experiences

Our clients describe their own experiences with Strong Craft Regen. Their stories are personal accounts, not clinical studies or a promise of how a particular treatment will work for you.

Read Client Stories

Other Treatments

Next-Generation MSC Therapy

Learn More

Peptide Therapy

Learn More

IV Therapy

Learn More

Biologics

Learn More
Evidence status Evidence varies by product and use

Take the First Step Today

Get on a free discovery call with us. We'll talk through your situation and what you want help with. Then we can discuss whether a clinical assessment is the right next step.